Section Arrow
NOTV.NASDAQ
- Inotiv
Quotes are at least 15-min delayed:2024/09/28 16:00 EDT
Last
 1.58
+0.04 (+2.60%)
Day High 
1.66 
Prev. Close
1.54 
1-M High
1.93 
Volume 
97.64K 
Bid
1.46
Ask
1.64
Day Low
1.545 
Open
1.55 
1-M Low
1.227 
Market Cap 
40.05M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 1.66 
20-SMA 1.54 
50-SMA 1.65 
52-W High 11.4166 
52-W Low 1.227 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.84/--
Enterprise Value
439.46M
Balance Sheet
Book Value Per Share
7.00
Cash Flow
Cash Flow Yield
0.36
Income Statement
Total Revenue
572.43M
Operating Revenue Per Share
2.62
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ME23andMe Holding Co0.2941-0.0241-7.57%-- 
OPKOPKO Health1.52+0.03+2.01%-- 
MYNZMainz Biomed NV0.247+0.0331+15.47%-- 
AAgilent Technologies148.06+1.32+0.90%30.51PE
QGENQiagen NV45.24+0.22+0.49%130.2PE
Quotes are at least 15-min delayed:2024/09/28 16:00 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates,as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.